Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System.
Barbieri MA, Russo G, Sorbara EE, Cicala G, Franchina T, Santarpia M, Speranza D, Spina E, Silvestris N. Barbieri MA, et al. Among authors: santarpia m. Front Oncol. 2023 Oct 31;13:1268672. doi: 10.3389/fonc.2023.1268672. eCollection 2023. Front Oncol. 2023. PMID: 38023143 Free PMC article.
Usefulness of predictive tests for cancer treatment.
Rosell R, Cuello M, Cecere F, Santarpia M, Reguart N, Felip E, Taron M. Rosell R, et al. Among authors: santarpia m. Bull Cancer. 2006 Aug;93(8):E101-8. Bull Cancer. 2006. PMID: 16935774 Free article. Review.
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
Santarpia M, Magri I, Sanchez-Ronco M, Costa C, Molina-Vila MA, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Benlloch S, Viteri S, Gasco A, Mederos N, Carcereny E, Taron M, Rosell R. Santarpia M, et al. J Transl Med. 2011 Sep 27;9:163. doi: 10.1186/1479-5876-9-163. J Transl Med. 2011. PMID: 21951562 Free PMC article.
Applications of genomics in NSCLC.
Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O. Rosell R, et al. Among authors: santarpia m. Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Lung Cancer. 2005. PMID: 16557672 Review.
Emerging drugs for non-small-cell lung cancer.
Felip E, Santarpia M, Rosell R. Felip E, et al. Among authors: santarpia m. Expert Opin Emerg Drugs. 2007 Sep;12(3):449-60. doi: 10.1517/14728214.12.3.449. Expert Opin Emerg Drugs. 2007. PMID: 17874972 Review.
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.
de las Peñas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, Massuti B, Queralt C, Botia M, Garcia-Gomez R, Isla D, Cobo M, Santarpia M, Cecere F, Mendez P, Sanchez JJ, Rosell R; Spanish Lung Cancer Group. de las Peñas R, et al. Among authors: santarpia m. Ann Oncol. 2006 Apr;17(4):668-75. doi: 10.1093/annonc/mdj135. Epub 2006 Jan 11. Ann Oncol. 2006. PMID: 16407418 Free article.
Predicting the outcome of chemotherapy for lung cancer.
Rosell R, Cecere F, Santarpia M, Reguart N, Taron M. Rosell R, et al. Among authors: santarpia m. Curr Opin Pharmacol. 2006 Aug;6(4):323-31. doi: 10.1016/j.coph.2006.01.011. Epub 2006 Jun 12. Curr Opin Pharmacol. 2006. PMID: 16765644 Review.
Predicting response to chemotherapy with early-stage lung cancer.
Rosell R, Taron M, Massuti B, Mederos N, Magri I, Santarpia M, Sanchez JM. Rosell R, et al. Among authors: santarpia m. Cancer J. 2011 Jan-Feb;17(1):49-56. doi: 10.1097/PPO.0b013e3182091fa3. Cancer J. 2011. PMID: 21263267 Review.
Applications of genomics in NSCLC.
Rosella R, Cobo M, Isla D, Miguel Sanchez J, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniza O. Rosella R, et al. Among authors: santarpia m. Lung Cancer. 2005 Dec;50S2:S33-S40. Lung Cancer. 2005. PMID: 16551521
130 results